Skip to main content
Clinical Trials/DRKS00024981
DRKS00024981
Completed
Phase 4

The use of Virtual Reality in psychotherapy for depression - DeepVR

niversitätsklinikum Düsseldorf, Klinisches Institut für Psychosomatische Medizin und Psychotherapie0 sites24 target enrollmentApril 7, 2021

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
F32
Sponsor
niversitätsklinikum Düsseldorf, Klinisches Institut für Psychosomatische Medizin und Psychotherapie
Enrollment
24
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 7, 2021
End Date
November 19, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Düsseldorf, Klinisches Institut für Psychosomatische Medizin und Psychotherapie

Eligibility Criteria

Inclusion Criteria

  • Depression symptomatology (ICD\-10: F32 \- 34\)
  • \- Inpatient treatment at the clinic for Psychosomatics and Psychotherapy, LVR\-Klinikum Düsseldorf

Exclusion Criteria

  • \- COVID\-19 disease in an infectious phase or symptoms suggestive of COVID\-19 disease.
  • \- Last alcohol consumption less than 8 hours ago
  • \- insufficient knowledge of the German language
  • \- uncorrected visual loss and visual disturbances
  • \- insufficiently corrected hearing
  • \- Neurological/psychiatric pre\-existing diseases affecting the vestibular organ, impairing the sense of balance or altering visual perception (e.g. Meniere's disease, dementia, post\-stroke condition, psychosis)
  • \- known epilepsy
  • \- taking medications that affect eye movements
  • (lithium, carbamazepine, lamotrigine, topiramate, phenytoin, risperidone, haloperidol, phenobarbital or primidone)
  • \- a body mass index (BMI) less than or equal to 17

Outcomes

Primary Outcomes

Not specified

Similar Trials